Standard BioTools agrees to sell microfluidics unit to Archimed

October 5, 2026 4:05 PM EDT Send to a Friend
Standard BioTools Inc. (NASDAQ: LAB) has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED, a healthcare-focused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login